Medicine and Dentistry
Prospective Cohort Study
66%
Nephropathy
51%
All Cause Mortality
46%
Cardiovascular System
42%
Chronic Kidney Disease
35%
Hazard Ratio
35%
Urinary System
35%
ANCA Associated Vasculitis
33%
Cohort Analysis
30%
Myeloperoxidase
29%
Rapidly Progressive Glomerulonephritis
29%
Minimal Change Disease
29%
Proteinuria
29%
Peritoneal Dialysis
29%
Retrospective Cohort Study
29%
Pulmonary Hemorrhage
26%
Proportional Hazards Model
24%
Kidney Function
22%
Creatinine
22%
Microscopic Polyangiitis
22%
Nephrotic Syndrome
22%
Leukapheresis
20%
Granulocytapheresis
20%
Isotopes of Calcium
18%
Serum Albumin
17%
Combination Therapy
17%
Human Study
16%
Ischemic Heart Disease
16%
Observational Study
16%
Renal Biopsy
16%
Immunoglobulin
16%
Continuous Ambulatory Peritoneal Dialysis
16%
Outpatient
16%
Parathyroid Hormone Release
14%
Immunoglobulin G4
14%
Intraperitoneal Drug Administration
14%
Amyloid
14%
Patient with Alzheimer's Disease
14%
Short Term Survival
14%
Nephrosclerosis
14%
Hypouricemia
14%
Brain Natriuretic Peptide
14%
Lupus Nephritis
14%
Fibrosis
14%
Immunoglobulin A Antibody
14%
Hemadsorption
14%
Pulse Rate
14%
Brain Ischemia
14%
22 Oxacalcitriol
14%
Resting Heart Rate
14%
Pharmacology, Toxicology and Pharmaceutical Science
Prospective Cohort Study
100%
All Cause Mortality
57%
Cohort Study
40%
Chronic Kidney Failure
36%
Creatinine
30%
Ascites
29%
Disease
29%
Proteinuria
29%
Remission
29%
Combination Therapy
26%
Infection
22%
Kidney Disease
21%
Renin
18%
Angiotensin
18%
Nephrotic Syndrome
18%
Human Study
17%
Clinical Study
17%
Ischemic Heart Disease
16%
Nephrosclerosis
14%
Short Term Survival
14%
Inflammation
14%
Amyloid
14%
Sodium Glucose Cotransporter 2 Inhibitor
14%
Lung Hemorrhage
14%
Immunoglobulin G4
14%
Dapagliflozin
14%
Parathyroid Hormone
14%
Hyperuricemia
14%
Antihypertensive Agent
14%
Kidney Polycystic Disease
14%
Brain Natriuretic Peptide
14%
Neutrophil Gelatinase Associated Lipocalin
14%
Doxazosin
14%
Alzheimer's Disease
14%
22 Oxacalcitriol
14%
Rapidly Progressive Glomerulonephritis
14%
Heart Disease
14%
Transferrin Receptor
14%
Vitamin D Receptor
14%
Fibroblast Growth Factor 23
14%
Lanthanum Carbonate
14%
Aortic Stenosis
14%
Tolvaptan
14%
Uric Acid
14%
Microscopic Polyangiitis
14%
Brain Ischemia
14%
Immunoglobulin
14%
Focal Glomerulosclerosis
14%
Paraprotein
14%
Monoclonal Immunoglobulinemia
14%
Keyphrases
Dialysis Initiation
36%
Multicenter Cohort Study
32%
Incident Dialysis Patients
29%
Minimal Change Disease
29%
Remission of Proteinuria
29%
Japan
24%
All-cause Mortality
22%
Nephrotic Syndrome
22%
Infection-related Mortality
19%
Hazard Ratio
19%
Prospective Cohort Study
18%
Adult Patients
17%
Confidence Interval
16%
Infection Risk
14%
Cognitive Function
14%
Oral Steroids
14%
Short-term Survival
14%
IgG4-related Kidney Disease
14%
Coronary Artery Disease
14%
Renal Hypouricemia
14%
IgA Antibody
14%
Lupus Nephritis
14%
Doxazosin
14%
Renin-angiotensin System Blockers
14%
Post-marketing Prospective Study
14%
Potential Therapeutic Strategies
14%
Serum Uric Acid
14%
Hyperuricemia
14%
Alzheimer's Disease
14%
Serum Albumin Concentration
14%
Reticulocyte Hemoglobin Content
14%
Hypochromic Red Blood Cells
14%
Serum Iron Level
14%
Transferrin Receptor 1 (TfR1)
14%
Sodium Zirconium Cyclosilicate
14%
Resting Heart Rate
14%
Heart Disease
14%
Heart Rate
14%
Dialysis Efficiency
14%
External Pressure
14%
Vitamin D Receptor Activator
14%
Fibroblast Growth Factor 23 (FGF23)
14%
Filtration Method
14%
Hydrothorax
14%
Lanthanum Carbonate
14%
Early Remission
14%
Dialysis-dependent
14%
Cancerous Ascites
14%
Concentrated Ascites Reinfusion Therapy
14%
Internal Pressure
14%